pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 2·1 min read
save

Citing 'dangerous deals,' lawmakers propose China restrictions

A bipartisan group of Michigan lawmakers released a new bill that could greatly stifle the booming cross-border deals spree between Chinese and American biotechs. Rep. John Moolenaar (R-MI) and Rep. Debbie Dingell (D-MI) on Tuesday ...

Jun 2, 2026·read at Endpoints ↗

Rep. John Moolenaar (R-MI) (Lenin Nolly/Sipa USA/Sipa via AP Images) June 2, 2026 08:00 AM EDT DealsChinaPharmaFDA+ Ex­clu­sive: Bi­par­ti­san group of law­mak­ers un­veil new bill to re­strict Chi­na biotech Max Bayer Senior Reporter A bi­par­ti­san group of Michi­gan law­mak­ers re­leased a new bill that could great­ly sti­fle the boom­ing cross-bor­der deals spree be­tween Chi­nese and Amer­i­can biotechs. Rep … Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
93 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 7h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 10h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 11h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 11h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 12h agoHealth tech investors are looking at bigger betsEndpoints